Preneoplastic lesions fimbria pan-proteomic studies establish the fimbriectomy benefit for BRCA1/2 patients and identify early diagnosis markers of HGSC
M. Wisztorski, P. saudemont, s. aboulouard, t. cardon, f. narducci, y.-m. robin, A.-s. Lemaire, D. Bertin, F. Kobeissy, E. Leblanc, I. Fournier, M. Salzet
The paper analyzes proteomic data from preneoplastic lesions in fallopian tubes to identify early diagnostic markers for HGSC and support fimbriectomy benefits for BRCA1/2 patients.
bioRxiv · Oct 4, 2020 · PreprintCancer Biology